CD93

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, CD93 mutation is significantly associated with the RNA expression of many other genes, with 4,773 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible CD93-associated genes across cancer lineages are METTL17, TOP3B, and E2F1. Each is linked with CD93 in more than 3 cancer types. Because this analysis shows association rather than direction, both CD93-to-partner and partner-to-CD93 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, METTL17 grouped by CD93-low versus CD93-high in LUAD.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (CD93→partner) and Y-score (partner→CD93) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LUADMETTL17 →+0.501+3.333.004.00534
SKCMTOP3B →+0.128+1.507<.001.00634
UCECE2F1 →+0.586+1.874.003.00234
UCECTIMM44 →+0.341+2.705<.001<.00134
UCECACBD5 →+0.533+2.099<.001<.00134
UCECPDCD10 →+0.428+2.016.006.00134
Each partner links to its Q-omics profile. Showing the 6 strongest of 4,773 associations by consensus.

METTL17 by CD93 expression — LUAD

Box plot of METTL17 in CD93-low vs CD93-high samples in LUAD.

Explore this box plot interactively →

Exploration